Pathological response and serum VEGF changes during chemoradiotherapy for esophageal carcinoma-Reference-Cited by-同舟云学术

Pathological response and serum VEGF changes during chemoradiotherapy for esophageal carcinoma

Published:2019-05 Issue:20 Volume:98 Page:e15627
ISSN:0025-7974
Container-title:Medicine
language:en
Short-container-title:

Author:

Wang Jian,Yu Jing-Ping,Ni Xin-Chu,Sun Zhi-Qiang,Sun Wei,Nie Bin,Sun Su-Ping,Wang Jian-Lin

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

General Medicine

Reference20 articles.

1. Pathologic response during chemo-radiotherapy and variation of serum VEGF levels could predict effects of chemo-radiotherapy in patients with esophageal cancer;Yu;Asian Pac J Cancer Prev,2015

2. Chemoradiotherapy of locally advanced esophageal cancer: long-term follow-up of a prospective randomized trial (RTOG 85-01). Radiation Therapy Oncology Group;Cooper;JAMA,1999

3. Phase III trial of protracted compared with split-course chemoradiation for esophageal carcinoma: Federation Francophone de Cancerologie Digestive 9102;Crehange;J Clin Oncol,2007

4. [Relation between pathologic tumor response to preoperative radiotherapy and the prognosis in patients with esophageal carcinoma];Ou;Zhonghua Zhong Liu Za Zhi,2003

5. High serum levels of vascular endothelial growth factor-A and transforming growth factor-beta1 before neoadjuvant chemoradiotherapy predict poor outcomes in patients with esophageal squamous cell carcinoma receiving combined modality therapy;Cheng;Ann Surg Oncol,2014

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. A systematic review of circulating predictive and prognostic biomarkers to aid the personalised use of radiotherapy in the radical treatment of patients with oesophageal cancer;Radiotherapy and Oncology;2024-06

2. Enhancing the management of locally advanced head and neck malignancies and cases with local/neck recurrence and metastasis through the integration of anlotinib with concurrent radiochemotherapy;Anti-Cancer Drugs;2024-05-27

3. Vascular Endothelial Growth Factor Family and Head and Neck Squamous Cell Carcinoma;Anticancer Research;2023-09-29

4. Investigating the predictive value of vascular endothelial growth factor in the evaluation of treatment efficacy and prognosis for patients with non-surgical esophageal squamous cell carcinoma;Frontiers in Oncology;2022-10-26